No substrate information.
Transporter |
Synonyms |
Inhibitor |
IC50 (μM) |
Ki (μM) |
Substrate used |
Cell System |
Reference |
ABCC3 |
MRP3 |
Ivermectin |
- |
2.7 |
Benzbromarone |
Sf9 cell membranes |
Lespine, 2006 |
ABCB1 |
MDR1, P-gp |
Ivermectin |
9 |
|
Calcein AM |
Caco-2 cells |
Eneroth, 2001 |
ABCB1 |
MDR1, P-gp |
Ivermectin |
0.1 |
|
Calcein AM |
MDR1 expressing LLC-PK1 cells |
Schwab, 2003 |
mouse_Abcb1a |
Mdr, Pgp, Pgy, Mdr3, P-gp, Abcb4, Mdr1a |
Ivermectin |
0.5 |
|
Calcein AM |
Mouse mdr1a expressing LLC-PK1 cells |
Schwab, 2003 |
mouse_Abcb1b |
mdr, Mdr1, Pgy1, Abcb1, Mdr1b, Pgy-1 |
Ivermectin |
0.5 |
|
Calcein AM |
Mouse mdr1b expressing LLC-PK1 cells |
Schwab, 2003 |
ABCC1 |
MRP1 |
Ivermectin |
3.8 |
|
Calcein AM |
HL60 cells |
Lespine, 2006 |
ABCB1 |
MDR1, P-gp |
Ivermectin |
10.9 |
|
Doxorubicin |
B16/F10 cells |
Bain, 1996 |
ABCG2 |
BCRP, MXR |
Ivermectin |
2.8 |
1.4 |
Estrone sulfate |
BCRP membrane vesicles |
Jani, 2011 |
ABCC1 |
MRP1 |
Ivermectin |
- |
0.5 |
N-ethylmaleimide-GS |
Sf9 cell membranes |
Lespine, 2006 |
ABCC2 |
MRP2, cMOAT |
Ivermectin |
- |
3.6 |
Probenecid |
Sf9 cell membranes |
Lespine, 2006 |
ABCB1 |
MDR1, P-gp |
Ivermectin |
0.1 |
|
Rhodamine 123 |
Caco-2 cells |
Griffin, 2005 |
mouse_Abcb1a |
Mdr, Pgp, Pgy, Mdr3, P-gp, Abcb4, Mdr1a |
Ivermectin |
0.4 |
|
Rhodamine 123 |
LLC-PK1 cells |
Lespine, 2006 |
ABCB1 |
MDR1, P-gp |
Ivermectin |
- |
0.06 |
Verapamil |
Sf9 cell membranes |
Lespine, 2006 |
No drug-drug interaction information.